Ignite Creation Date:
2025-12-24 @ 7:40 PM
Ignite Modification Date:
2026-03-13 @ 11:55 AM
Study NCT ID:
NCT03366103
Status:
TERMINATED
Last Update Posted:
2023-10-17
First Post:
2017-12-07
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Navitoclax and Vistusertib in Treating Patients With Relapsed Small Cell Lung Cancer and Other Solid Tumors
Sponsor:
National Cancer Institute (NCI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
NCI-2017-00037
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None